Top

Systematic Reviews

Published in:

Open Access 01-12-2024 | Type 1 Diabetes | Systematic review update

Effect of glycemic control on cognitive function in patients with type 1 diabetes mellitus: a systematic review and meta-analysis

Authors: Wenting Hua, Zouxi Du, Tingting Lu, Limin Tian

Published in: Systematic Reviews | Issue 1/2024

Abstract

Background

It is controversial whether the level of glycemic control in patients with type 1 diabetes mellitus (T1DM) correlates with reduced cognitive function. This study explored the influence of glycemic management quality on cognitive function in T1DM patients by examining the association between glycemic control level and impaired cognitive function.

Methods

The electronic databases PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, China Science and Technology Journal database, Wanfang database, and China Biology Medicine disc database were systematically searched to identify eligible studies published before January 2023. Search, selection, and data extraction were performed by two independent reviewers. RevMan 5.4 software was used for meta-analysis, and standardized mean difference (SMD) between groups was calculated.

Results

Six studies involving 351 patients with T1DM were included in this study. Compared with T1DM subjects with good glycemic control, those with poor glycemic control performed worse in full-scale intellectual quotient (P = 0.01, SMD = −0.79, 95%CI = −1.42 to −0.17), but no significant differences were observed in verbal intellectual quotient (P = 0.08, SMD = −1.03, 95%CI = −2.20 to 0.13), memory (P = 0.05, SMD = −0.41, 95%CI = −0.82 to 0.00), and attention (P = 0.23, SMD = −0.26, 95%CI = −0.69 to 0.16).

Conclusions

T1DM patients with suboptimal glycemic control may have a worse cognitive function, mainly focusing on the full-scale intellectual quotient. The current study highlights the significance of maintaining satisfactory glycemic control in T1DM patients to improve their health status and quality of life. Standardized tests should be employed in clinical neuropsychological practice to provide early and complete cognitive assessment of individuals with poor glycemic control.

Systematic review registration

The study protocol has been registered in the PROSPERO database (CRD42023390456).

Available only for authorised users

Cloete L. Diabetes mellitus: an overview of the types, symptoms, complications and management. Nurs Stand. 2022;37(1):61–6. https://doi.org/10.7748/ns.2021.e11709.CrossRefPubMed

International Diabetes Federation. IDF Diabetes Atlas 10th Edition 2021. https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html.

Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–s38. https://doi.org/10.2337/dc22-S002.

Syed FZ. Type 1 Diabetes mellitus. Ann Int Med. 2022;175(3):ITC33–48. https://doi.org/10.7326/aitc202203150.CrossRefPubMed

Pan WT, Liu PM, Ma D, Yang JJ. Advances in photobiomodulation for cognitive improvement by near-infrared derived multiple strategies. J Transl Med. 2023;21(1):135. https://doi.org/10.1186/s12967-023-03988-w.CrossRefPubMedPubMedCentral

Yuan L, Luan D, Xu X, Yang Q, Huang X, Zhao S, et al. Altered attention networks in patients with thyroid dysfunction: a neuropsychological study. Horm Behav. 2020;121:104714. https://doi.org/10.1016/j.yhbeh.2020.104714.CrossRefPubMed

Yu JH, Kim REY, Park SY, Lee DY, Cho HJ, Kim NH, et al. Association of long-term hyperglycaemia and insulin resistance with brain atrophy and cognitive decline: a longitudinal cohort study. Diabetes Obes Metab. 2022; https://doi.org/10.1111/dom.14958.

Rawlings AM, Sharrett AR, Albert MS, Coresh J, Windham BG, Power MC, et al. The association of late-life diabetes status and hyperglycemia with incident mild cognitive impairment and dementia: the ARIC study. Diabetes Care. 2019;42(7):1248–54. https://doi.org/10.2337/dc19-0120.CrossRefPubMedPubMedCentral

Zhou C, Dong C, Xie Z, Hao W, Fu C, Sun H, et al. Sex-specific associations between diabetes and dementia: the role of age at onset of disease, insulin use and complications. Biol Sex Differ. 2023;14(1):9. https://doi.org/10.1186/s13293-023-00491-1.CrossRefPubMedPubMedCentral

10.

Sharma S, Brown CE. Microvascular basis of cognitive impairment in type 1 diabetes. Pharmacol Ther. 2022;229:107929. https://doi.org/10.1016/j.pharmthera.2021.107929.CrossRefPubMed

11.

Arffman M, Hakkarainen P, Keskimäki I, Oksanen T, Sund R. Long-term and recent trends in survival and life expectancy for people with type 1 diabetes in Finland. Diabetes Res Clin Pract. 2023;198:110580. https://doi.org/10.1016/j.diabres.2023.CrossRefPubMed

12.

Macedo LBC, Foss MP, Galera CA. Cognitive impairments in type 1 diabetes mellitus: integrative review. Psicologia - Teoria e Prática. 2023;25(1) https://doi.org/10.5935/1980-6906/ePTPPA14344.en.

13.

Chaytor NS, Barbosa-Leiker C, Ryan CM, Germine LT, Hirsch IB, Weinstock RS. Clinically significant cognitive impairment in older adults with type 1 diabetes. J Diabetes Complicat. 2019;33(1):91–7. https://doi.org/10.1016/j.jdiacomp.2018.04.003.CrossRef

14.

Shigemoto S, Imbe H, Fujisawa R, Sasagawa A, Watanabe D, Tachibana M, et al. Decreased cognitive function is associated with preceding severe hypoglycemia and impaired blood glucose control in the elderly individuals with type 1 diabetes. Diabetol Int. 2022;13(4):679–86. https://doi.org/10.1007/s13340-022-00588-9.CrossRefPubMedPubMedCentral

15.

Ohmann S, Popow C, Rami B, König M, Blaas S, Fliri C, et al. Cognitive functions and glycemic control in children and adolescents with type 1 diabetes. Psychol Med. 2009;40(1):95–103. https://doi.org/10.1017/s0033291709005777.CrossRefPubMed

16.

Moola SMZ, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, et al. Chapter 7: systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis JBI; 2020. https://doi.org/10.46658/JBIMES-20-08.CrossRef

17.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71. https://doi.org/10.1136/bmj.CrossRefPubMedPubMedCentral

18.

Stanisławska-Kubiak M, Mojs E, Wójciak RW, Piasecki B, Matecka M, Sokalski J, et al. An analysis of cognitive functioning of children and youth with type 1 diabetes (T1DM) in the context of glycemic control. Eur Rev Med Pharmacol Sci. 2018;22(11):3453–60. https://doi.org/10.26355/eurrev_201806_15170.CrossRefPubMed

19.

Higgins JPT, Li T, Deeks JJ, editors. Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org/handbook.

20.

The Cochrane Collaboration. Review Manager (RevMan) [computer program]. Version 5.4: The Cochrane Collaboration. 2020.

21.

Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. Bmj. 2011;342:d549. https://doi.org/10.1136/bmj.d549.CrossRefPubMed

22.

Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94. https://doi.org/10.1016/j.jclinepi.2010.04.026.CrossRefPubMed

23.

Zihl J, Schaaf L, Zillmer EA. The relationship between adult neuropsychological profiles and diabetic patients’ glycemic control. Appl Neuropsychol. 2010;17(1):44–51. https://doi.org/10.1080/09084280903526133.CrossRefPubMed

24.

Abo-El-Asrar M, Andrawes NG, Rabie MA, El-Gabry DA, Khalifa AG, El-Sherif M, et al. Cognitive functions in children and adolescents with early-onset diabetes mellitus in Egypt. Appl Neuropsychol Child. 2016;7(1):21–30. https://doi.org/10.1080/21622965.2016.1224186.CrossRefPubMed

25.

He J, Li S, Liu F, Zheng H, Yan X, Xie Y, et al. Glycemic control is related to cognitive dysfunction in Chinese children with type 1 diabetes mellitus. J Diabetes. 2018;10(12):948–57. https://doi.org/10.1111/1753-0407.12775.CrossRefPubMed

26.

Kaufmann L, Pixner S, Starke M, Zotter S, Köhle J, Meraner D, et al. Neurocognition and brain structure in pediatric patients with type 1 diabetes. Journal of Pediatric. Neuroradiol. 2012;1(1):25–35. https://doi.org/10.3233/PNR-2012-005.CrossRef

27.

Kirchhoff BA, Jundt DK, Doty T, Hershey T. A longitudinal investigation of cognitive function in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2016;18(6):443-i449 https://doi.org/10.1111/pedi.12414.

28.

Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, et al. Long-term effect of diabetes and its treatment on cognitive function. New England j med. 2007;356(18):1842–52. https://doi.org/10.1056/NEJMoa066397.CrossRef

29.

Lancrei HM, Yeshayahu Y, Grossman ES, Berger I. Sweet but sour: impaired attention functioning in children with type 1 diabetes mellitus. Front Human Neurosci. 2022;16 https://doi.org/10.3389/fnhum.2022.895835.

30.

Bolli GB, Porcellati F, Lucidi P, Fanelli CG. The physiological basis of insulin therapy in people with diabetes mellitus. Diabetes Res Clin Pract. 2021;175:108839. https://doi.org/10.1016/j.diabres.2021.CrossRefPubMed

31.

Schoenle EJ, Schoenle D, Molinari L, Largo RH. Impaired intellectual development in children with type I diabetes: association with HbA(1c), age at diagnosis and sex. Diabetologia. 2002;45(1):108–14. https://doi.org/10.1007/s125-002-8250-6.CrossRefPubMed

32.

Mauras N, Buckingham B, White NH, Tsalikian E, Weinzimer SA, Jo B, et al. Impact of type 1 diabetes in the developing brain in children: a longitudinal study. Diabetes Care. 2021;44(4):983–92. https://doi.org/10.2337/dc20-2125.CrossRefPubMedPubMedCentral

33.

Rom S, Zuluaga-Ramirez V, Gajghate S, Seliga A, Winfield M, Heldt NA, et al. Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both diabetes mellitus (DM) type 1 and type 2 mouse models. Mol Neurobiol. 2019;56(3):1883–96. https://doi.org/10.1007/s12035-018-1195-5.CrossRefPubMed

34.

Ahmed A, Zeng G, Jiang D, Lin H, Azhar M, Farooq AD, et al. Time-dependent impairments in learning and memory in Streptozotocin-induced hyperglycemic rats. Metab Brain Dis. 2019;34(5):1431–46. https://doi.org/10.1007/s11011-019-00448-7.CrossRefPubMed

35.

Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res. 1998;800(1):125–35. https://doi.org/10.1016/s0006-8993(98)00510-1.CrossRefPubMed

36.

Ma WX, Tang J, Lei ZW, Li CY, Zhao LQ, Lin C, et al. Potential biochemical mechanisms of brain injury in diabetes mellitus. Aging Dis. 2020;11(4):978–87. https://doi.org/10.14336/ad.2019.0910.CrossRefPubMedPubMedCentral

37.

Muriach M, Flores-Bellver M, Romero FJ, Barcia JM. Diabetes and the brain: oxidative stress, inflammation, and autophagy. Oxid Med Cell Longev. 2014;2014:102158. https://doi.org/10.1155/2014/102158.CrossRefPubMedPubMedCentral

38.

Shukla V, Shakya AK, Perez-Pinzon MA, Dave KR. Cerebral ischemic damage in diabetes: an inflammatory perspective. J Neuroinflammation. 2017;14(1):21. https://doi.org/10.1186/s12974-016-0774-5.CrossRefPubMedPubMedCentral

39.

Lima J, Moreira NCS, Sakamoto-Hojo ET. Mechanisms underlying the pathophysiology of type 2 diabetes: from risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia. Mutat Res Genet Toxicol. Environ Mutagen. 2022;874-875:503437. https://doi.org/10.1016/j.mrgentox.2021.503437.CrossRef

40.

Bolo NR, Musen G, Jacobson AM, Weinger K, McCartney RL, Flores V, et al. Brain activation during working memory is altered in patients with type 1 diabetes during hypoglycemia. Diabetes. 2011;60(12):3256–64. https://doi.org/10.2337/db11-0506.CrossRefPubMedPubMedCentral

Title: Effect of glycemic control on cognitive function in patients with type 1 diabetes mellitus: a systematic review and meta-analysis
Authors: Wenting Hua
Zouxi Du
Tingting Lu
Limin Tian
Publication date: 01-12-2024
Publisher: BioMed Central
Keywords: Type 1 Diabetes
Hyperglycemia
Published in: Systematic Reviews / Issue 1/2024
Electronic ISSN: 2046-4053
DOI: https://doi.org/10.1186/s13643-023-02433-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effect of glycemic control on cognitive function in patients with type 1 diabetes mellitus: a systematic review and meta-analysis

Abstract

Background

Methods

Results

Conclusions

Systematic review registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Systematic review registration

Please log in to get access to this content

Other articles of this Issue 1/2024

The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis

The effects of manual therapy in pain and safety of patients with knee osteoarthritis: a systematic review and meta-analysis

Efficacy and safety of antibiotics for treatment of leptospirosis: a systematic review and network meta-analysis

Building capacity for network meta-analysis in Sub-Saharan Africa: reflections and future direction

Addressing the challenges of reconstructing systematic reviews datasets: a case study and a noisy label filter procedure

Understanding how therapeutic exercise prescription changes outcomes important to patients with persistent non-specific low back pain: a realist review protocol